Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10k report due March 31. Shares updated on Feb 28, 29 and Mar 1. All showing the same 10.5 million shares. Weird usually there is an update every 2 weeks here.
Wow ascm and otcn getting their butts kicked today. Good sign.
If there is enough pressure on ascm on the ask...could squeeze nicely.
Just watching but good luck interesting to see what happens here.
If they hire a new doctor we see 0.05 again. That will be a sign that research team is up and running again.
Hopefully some sort of reverse merger here...an ai or crypto one would be massive.
For now I guess we wait until the next quarterly report.
10m shares still a great structure...and like I've been saying for months I don't think they got rid of that 7 million in debt for nothing.
Good luck everybody.
There are no doctors left here. I still think they want to move on from pharma and do something else.
Share count here still good let's see what happens.
At this point anybodys guess.
Looks like the old atrx noteholders cashed out on bdrx today.
Update from company needed...either we fly high or put a fork in it. The sooner we know the better
Atrx used one product in a deal and the other one left terminated.
Genius to give uo the product in exchange to pay down debt.
To me looks like they want a new business plan or merger to come in. I also think I could be wrong.
Waiting patiently on company profile update...press release...8k...something lol.
Let's see what happens within the next few weeks and months...
Tons of pinks with our share structure that are 0.30+.
A few things:
1. Simply pay the fee and otcqb is back.
2. Merger
3. Bankruptcy
4. They don't care for otcqb anymore as they currently have no products and no operations.
Could be any of the above.
If it's simply payment then within the next 2 weeks we should see a return to otcqb.
A lot more than that look at post 3708.
Could be something that isn't disclosed could be as simple as an updated float...
Also if the company is in bankruptcy they can't stay on otcqb...on the other end if the company is involved in some kind of takeover/merger they must apply again for otcqb.
Could be anything really so let's keep guessing lol
I am thinking it might be more than a simple 3500 payment. If it is though I'm good with that lol.
Could be something else the company needs to disclose.
Shares still increasing so debt still exists here. Need to see the 10q and an update.
Anything can happen here I've seen it all. Right now we are in the dark. But given what I have seen in the filings...the deal that just closed...and the share count...still hopeful here.
They didn't come all this way to go bankrupt....they could've just done that 3 years ago.
Anybody here wanna take a guess why otcqb to pink? I'm still shaking my head on this one...
Up 447,000 shares
$ATRX
0.0150
Pink Current, AS: 180M, OS: 9.6M
Outstanding Shares Updated:
9,149,760 (2024-01-30)
9,597,029 (2024-02-01)
Difference: +4.9% (+447K)
Up 9.1 to 9.5...looks like that dtc increase is now reflective of shares outstanding.
Which is odd both should update at the same time...
They were pink in the past and it looks like disclosures were always otcqb based before the move in 2022 to otcqb trading.
We need an update from management...now it's a coin toss heads or tails. Gotta love and hate the otc lol
Otcqb requirements below
https://www.otcmarkets.com/files/OTCQB_Standards.pdf
Might not be good here...well let's see.
Pink current...
Always speculation yes...just trying to piece things together here the best I can. Who knows what will happen maybe absolutely nothing for the next few years.
Well the stock is QB 9.1 million shares. From the filings it seems the management team wants to take a new path here.
They just did a deal with a nasdaq listed firm in exchange for their product. 7.8 million in debt wiped out. I don't know many other companies on otc that are capable of doing something like that...
Let's not forget the 640K in cash received in the deal also.
They ran it up to 1.8 cents....gather a short position and then convert shares. So noteholder is winning in two ways here.
Just my opinion.
Over 2 soon. Let's put these 1s behind us. We are potentially on the brink of huge things to come here!
Otcn on the ask is never a good sign. Note holder most likely otcn.
If a reverse merger ever happens here...unrestricted shares usually are not involved in the deal. Restricted shares or preffered stock are usually the main components the other company will take over.
But all shares will benefit :)
Unless the transfer agent is dumb and the total share count should be higher than what is showing...if dtc increases its restricted shares moving over to the retail side or simply because higher shares outstanding.
Higher dtc which I believe means restricted shares converted to shares held in a Depositary trust...aka retail float. From my own research.
This also happened 2 or 4 weeks ago
Dtc higher...share count the same.
ATRX SECURITY DETAILS
Share Structure
Market Cap Market Cap
141,821
01/30/2024
Authorized Shares
180,000,000
01/30/2024
Outstanding Shares
9,149,760
01/30/2024
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
6,687,395
01/30/2024
https://www.sec.gov/Archives/edgar/data/737207/999999999724000226/9999999997-24-000226-index.htm
It simply means the s1 is closed off. So uplist is off the table now...
So IMO 2 options:
New business plan or merger. They didn't pay off all that debt in December to declare bankruptcy...anything possible.
I just checked edgar looks like s1 from 2022 is now revoked and closed.
Maybe some more updates coming soon?
Massive dilution wow
As I've heard somebody say here the writing is on the wall...now will it stay there or wash away? Good night
Latest 10 Q
Nature of Business
We are dependent upon closing the previously announced transaction with Biodex
Hmmm I thought nature of business was pharma?
As I said a new path might be coming here for the company:
Adhera Therapeutics, Inc. and its wholly-owned subsidiaries(collectively “Adhera,” “we”, or the “Company”), historically focused on drug development and commercialization of “small molecule” drugs to treat Parkinson’s disease (PD) and Type 1 diabetes. More recently, as it has struggled to operate with very limited working capital, it has been seeking to license a diabetes drug to a publicly-traded Nasdaq company as described in Note 9.
August 2023 10 Q
To the extent that resources have been available, the Company has continued to work with its advisors in an effort to restructure our company and to identify potential strategic transactions to enhance the value of our company as such opportunities arise, including potential transactions and capital raising initiatives involving our current assets, as well as business combination transactions with operating companies. There can be no assurance that the Company will be successful at identifying any such transactions, that it will continue to have sufficient resources to actively attempt to identify such transactions, or that such transactions will be available upon terms acceptable to us or at all. If the Company does not complete any significant strategic transactions, or raise substantial additional capital, in the immediate future, it is likely that the Company will discontinue all operations and seek bankruptcy protection.
Ms. Stanley, CPA, is an accomplished financial professional with over a decade of financial leadership experience. She has broad finance and accounting experience including initial public offerings, mergers and acquisitions, reverse mergers, operations and management for life science and biotechnology companies.
Anything can happen here good or bad. I will stick with my gut and if I'm wrong i will take it and move on.